SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Medicus Pharma to Present at BIO-Europe 2026

The company says its chief medical officer will highlight its precision oncology focus, including its CD228V-targeted ADC and partner-ready therapeutic programs.

MDCX

Related stories